Edward Kliphuis

Partner at Sofinnova Partners

📍 Covibar Madrid, Community of Madrid, Spain🔄 Updated September 2026💼 14 investments📅 11 years investing🗓 Last invested Aug 2025
VC🌍 Spain
14
Total investments
3
Early stage
5
Mid stage
0
Late stage
11y
Years active

Portfolio

13 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2025
At Excelsior Sciences we are revolutionizing small molecule innovation by developing a new form of chemistry that machines can do and AI can use to accelerate the discovery and manufacture of small molecules. Our unique smart blocc approach quickly creates molecular solutions from automated synthesis-friendly, function-infused and AI-readable building blocks. These smart bloccs serve as tokens in a modular chemical “language” that enables AI to accelerate discovery and manufacturing, derive novel insights and define new functional frontiers for an array of industries and applications. We are the only company built on a proven, published track record of making real-world advances in multiple fields using automated small molecule synthesis coupled with AI, with the goal to spark an innovation renaissance of safer, more effective and more sustainable solutions to human and planetary challenges.
Board Member
Jan 2025
We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.
Board Member
Feb 2024
We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology.
Board Member
Aug 2023
Betteromics is a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform that accelerates innovation for life science companies. By seamlessly integrating cutting-edge science, streamlined processes, untamed data, and the power of generative AI, Betteromics empowers organizations to extract valuable insights from massive amounts of multimodal data across the entire drug lifecycle. Real-time insights and advanced signal detection, driven by GenAI, facilitate data-driven decision-making, enabling scientists and researchers to develop personalized medicine faster and more efficiently.
Board Member
Jun 2023
AI Development platform focused on computer vision
Board Member
Nov 2022
We believe that everyone - irrespective of who they are or where they live - deserve medications that work
Board Member
Oct 2022
Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical experts to build together a new approach to medical biology that is more understandable, personalized and relevant for the sake of patients.
Board Member
Apr 2019
Sonde Health is a health technology company with a voice-enabled symptom detection and monitoring platform for chronic and mental health conditions. Our products are based on patented and proprietary, best-in-class technology developed by amazing people with advanced audio signal processing, speech science and machine learning backgrounds. We analyze over 4,000 vocal features that reflect changes in your voice caused by the changing physiology of your body due to symptoms of disease. Sonde's platform is designed with people's privacy in mind, and work on most smartphones people already own, preventing you from having to wear something new or add anything to your busy life.
Board Member
Nov 2017
Wiliot powers your supply chain with continuous, scan-free visibility into item location and condition. The Wiliot Physical AI platform processes signals from battery-free Bluetooth sensors (IoT Pixels) using purpose-built AI and ML models. This enables real-time automated condition monitoring, inventory intelligence, and workflow optimization. Whether you have AI in place or are just starting, Wiliot delivers continuous, AI-ready data that drives ROI today and scales into advanced AI tomorrow. Trusted by leading global retailers and logistics companies, Wiliot’s platform processes billions of sensing events across millions of products every month. It integrates seamlessly into existing enterprise systems, enabling businesses to automate workflows, respond to issues instantly, and reduce waste—ensuring products arrive when and where they should, in perfect condition.
Board Member
Nov 2017
Biolinq has created a new Biowearable experience by using an array of electrochemical sensors so small you can barely feel them. Our metabolic health sensors work together to provide maximum reliability for continuous sensing applications. With the potential of multiple analytes such as glucose, ketones, and lactate, we provide an entirely new user experience with actionable metabolic health insights. Over the next 10 years we intend to bring Biosensing and Biowearables mainstream. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.
Board Member
Feb 2017
At Medisafe®, our mission is to be the worlds leading medication management platform, dedicated to engaging patients and putting them in control of their healthcare journey. We empower individuals to take charge of their health by providing a comprehensive solution that encompasses appointments, symptoms, measurements, reports, trials, connection with care teams and much more. Through the fusion of advanced technology and behavior science, Medisafe reimagines the treatment journey, offering personalized guidance tailored to each patients specific needs. Our digital technology forms the foundation of a holistic patient engagement platform, delivering scalable support that is customized to individuals in a meaningful way. By integrating existing patient support programs into our platform, we revolutionize the future model of patient care, resulting in improved health outcomes. With more than 10 million registered patients and caregivers relying on our platform, we have successfully delivered double-digit improvements in patient outcomes. Medisafe manages an astonishing two billion medication doses through iOS and Android smartphones and tablets. Our commitment to excellence is reflected in our average rating of 4.7 out of 5 stars and over 400,000 ratings and reviews. Medisafe fosters daily engagement rate that surpasses popular social media applications like Facebook or Twitter. As a HIPAA and GDPR compliant solution, we prioritize the security and privacy of our users data. Moreover, our ISO 27001:2013 and ISO 13485:2016 certifications underscore our dedication to maintaining the highest standards of quality and safety. At Medisafe, we strive to empower patients, enhance their healthcare experience, and ultimately improve their overall well-being.
Board Member
Jul 2016
Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! Were continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity/ disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases. And were always looking for game-changers to join our team – to help us change the status quo of medicine and ignite new hope for those living with cognitive deficits. Imagine what medicine can be®
Board Member
Feb 2015
Prexton Therapeutics SA is a pharmaceuticals company based out of 14 Ch. des Aulx, Plan-les-Ouates, Geneva, Switzerland.
Experience · 17 entries
All (17)
Investments (14)
Board (14)
2025
Board Member
Aug 2025
At Excelsior Sciences we are revolutionizing small molecule innovation by developing a new form of chemistry that machines can do and AI can use to accelerate the discovery and manufacture of small molecules. Our unique smart blocc approach quickly creates molecular solutions from automated synthesis-friendly, function-infused and AI-readable building blocks. These smart bloccs serve as tokens in a modular chemical “language” that enables AI to accelerate discovery and manufacturing, derive novel insights and define new functional frontiers for an array of industries and applications. We are the only company built on a proven, published track record of making real-world advances in multiple fields using automated small molecule synthesis coupled with AI, with the goal to spark an innovation renaissance of safer, more effective and more sustainable solutions to human and planetary challenges.
Board Member
Jan 2025
We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.
2024
Board Member
Feb 2024
We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology.
2023
Board Member
Aug 2023
Betteromics is a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform that accelerates innovation for life science companies. By seamlessly integrating cutting-edge science, streamlined processes, untamed data, and the power of generative AI, Betteromics empowers organizations to extract valuable insights from massive amounts of multimodal data across the entire drug lifecycle. Real-time insights and advanced signal detection, driven by GenAI, facilitate data-driven decision-making, enabling scientists and researchers to develop personalized medicine faster and more efficiently.
Board Member
Jun 2023
AI Development platform focused on computer vision
Show all 17 entries ↓
Investment activity
2015–2025 · 14 investments
2015220161201732019120222202322024120252
Recent (last 2 years)Earlier